| Roche Pharma (Schweiz) AG - Madopar 62.5, Kapseln | | 38096 | | 01 | | Madopar 62.5 | | Kapseln | | N04BA02 | | Levodopa and Decarboxylase Inhibitor | | 23.06.1978 | | |
| | Composition | | levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum K 90, magnesii stearas, Kapselhülle: E 172 (nigrum), E 171, E 132, gelatina, Drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Benserazide | 12.5 mg | | Levodopa | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Benserazide | 12.5 mg | | Levodopa | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | Ammoniae Solutio | 28 | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | | | | | | | | | Drucktinte | | | | | | Mannitol | | | | Per Centum | | | | | 90 | | | | | | | Propylenglycol | | | | Talcum | | |
| |
| | Teilbarkeit | | | -- | | | | Ja (sofort anwenden!) | | | | Nein | | | | Ja | | | | Die Kapseln dürfen erst unmittelbar vor der Verabreichung geöffnet werden, weil der Wirkstoff sehr instabil ist. [2] | | | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 095 | 100 Capsule(s) | 8.48 | 18.30 | B | SL | No |
|
|
